Mice Model Market

• Rising incidence of diseases is driving the market growth

The Global Mice Model Market Industry is poised for substantial growth, with projections indicating an increase from 1.68 USD Billion in 2024 to 3.25 USD Billion by 2035. This growth trajectory suggests a compound annual growth rate (CAGR) of 6.18% from 2025 to 2035, highlighting the increasing reliance on mice models in various research applications. The expansion of the market is likely driven by advancements in genetic engineering, rising demand for personalized medicine, and increased investment in biomedical research. These factors collectively contribute to a robust outlook for the Global Mice Model Market Industry.

Technological advancements in genetic engineering, particularly CRISPR and other gene-editing techniques, are transforming the Global Mice Model Market Industry. These innovations enable the creation of more precise and relevant animal models that closely mimic human diseases. Consequently, researchers can conduct more effective preclinical studies, leading to improved drug development processes. The market is projected to grow at a CAGR of 6.18% from 2025 to 2035, indicating a robust future driven by these advancements. As the industry evolves, the integration of cutting-edge genetic technologies will likely enhance the utility of mice models in various research applications.

Regulatory bodies worldwide are providing support for animal research, which positively impacts the Global Mice Model Market Industry. Guidelines and frameworks established by organizations promote the ethical use of animal models in research, ensuring that they are utilized responsibly and effectively. This regulatory support fosters an environment conducive to research and development, encouraging scientists to employ mice models in their studies. As a result, the market is projected to grow at a CAGR of 6.18% from 2025 to 2035, reflecting the ongoing commitment to uphold ethical standards while advancing scientific knowledge.

The Global Mice Model Market Industry experiences a notable surge in demand for personalized medicine, which is increasingly recognized for its potential to enhance treatment efficacy. As researchers seek to develop tailored therapies, the use of genetically modified mice models becomes essential for studying specific disease mechanisms. This trend is expected to drive the market's growth, as personalized medicine is projected to account for a significant portion of the pharmaceutical market by 2035. The Global Mice Model Market Industry is anticipated to reach 3.25 USD Billion by that year, reflecting a growing reliance on these models for drug development.

The Global Mice Model Market Industry benefits from increased investment in biomedical research, driven by both public and private sectors. Governments and organizations are recognizing the importance of animal models in understanding complex diseases and developing new therapies. This influx of funding supports the development of innovative mice models, which are crucial for preclinical testing. As a result, the market is projected to grow to 1.68 USD Billion in 2024, reflecting the heightened focus on research and development. This trend suggests a sustained commitment to advancing biomedical research, further solidifying the role of mice models in the industry.

The Global Mice Model Market Industry is significantly influenced by the growing focus on drug discovery and development. Pharmaceutical companies are increasingly utilizing mice models to evaluate the safety and efficacy of new compounds before clinical trials. This trend is driven by the need for faster and more cost-effective drug development processes. The market's growth is indicative of this shift, as it is expected to reach 3.25 USD Billion by 2035. The reliance on mice models for early-stage drug testing underscores their critical role in the pharmaceutical industry, facilitating the development of innovative therapies.

By region, the study provides the market insights into North America, Europe, Asia-Pacific and the Rest of the World. North America dominates the Mice Model Market for several reasons. Firstly, the region boasts a robust biomedical research ecosystem, with numerous academic institutions, pharmaceutical companies, and research organizations driving demand for mice models. Secondly, supportive government funding and regulatory frameworks encourage research and development activities in the region. Lastly, the presence of key market players and advanced infrastructure further strengthens North America's position as a leader in mice model research and development, contributing to its largest market share in the industry.

Further, the major countries studied in the market report are the US, Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 2: Mice Model Market Share By Region 2023 (USD Billion)

Source: Secondary Research, Primary Research, Market Research Future Database and Analyst Review

Europe Mice Model market accounts for the second-largest market share due to a well-established biomedical research infrastructure. Europe holds the second-largest market share in the Mice Model Market due to several factors. Firstly, the region features a well-established biomedical research infrastructure, with prominent academic institutions and research organizations driving demand for mice models. Secondly, supportive government initiatives and funding bolster research and development activities in Europe. Thirdly, the presence of leading pharmaceutical and biotechnology companies further contributes to the region's significant market share in mice model research and development.

Further, the German Mice Model market held the largest market share, and the UK Mice Model market was the fastest growing market in the European region.

The Asia-Pacific Mice Model Market is expected to grow at the fastest CAGR from 2025 to 2034. The Asia Pacific region is experiencing the highest Compound Annual Growth Rate (CAGR) in the Mice Model Market due to several factors. Firstly, increasing investment in biomedical research and development across countries like China, Japan, and India drives demand for mice models. Secondly, rising pharmaceutical and biotechnology activities, coupled with a growing focus on personalized medicine, accelerate the adoption of mice models for preclinical research. Lastly, expanding collaborations between academia and industry further fuel market growth in the Asia Pacific region.

Moreover, China’s Mice Model market held the largest market share, and the Indian Mice Model market was the fastest growing market in the Asia-Pacific region.

Leading players in the Mice Model Market are actively engaged in strategic initiatives to maintain their competitive edge. This includes expanding their product portfolios with innovative mice models, such as genetically engineered and humanized mice, to meet diverse market developments. Additionally, these players focus on enhancing their service offerings, including breeding, genotyping, and phenotyping services, to provide comprehensive solutions to researchers. Collaborations with academic institutions and pharmaceutical companies for research partnerships and licensing agreements also contribute to their competitive advantage.

Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the global Mice Model industry to benefit clients and increase the market sector. In recent years, the Mice Model industry has offered some of the most significant advantages to oncology. Major players in the Mice Model market, including Charles River Laboratories International, Inc., Taconic Biosciences, Inc., The Jackson Laboratory, Envigo, JANVIER Labs, genOway S.A., Horizon Discovery Group plc, Harbour BioMed, Crown Bioscience Inc., InVivos Pte Ltd. and Others, are attempting to increase market demand by investing in research and development operations.

Charles River Laboratories International, Inc. is a leading provider of mice models and related services in the Mice Model Market. With a global presence spanning North America, Europe, Asia Pacific, and other regions, Charles River offers a comprehensive portfolio of genetically engineered, immunodeficient, and humanized mice models tailored for preclinical research across various therapeutic areas. The company's extensive expertise in breeding, genotyping, and phenotyping services ensures the delivery of high-quality, reliable research models to pharmaceutical, biotechnology, academic, and government institutions worldwide.

Through strategic collaborations, acquisitions, and investments in technology and innovation, Charles River Laboratories continues to strengthen its position as a trusted partner in advancing biomedical research and drug discovery efforts aimed at addressing unmet medical needs.

Taconic Biosciences, Inc. is a prominent player in the Mice Model Market, offering a comprehensive range of genetically engineered mice models and related services. With a strong emphasis on innovation and quality, Taconic provides researchers worldwide with customized mice models tailored to specific research needs in various therapeutic areas. The company's extensive portfolio includes models for oncology, immunology, neurology, metabolic diseases, and more, facilitating preclinical research and drug discovery efforts.

Taconic's commitment to customer satisfaction, along with its expertise in breeding, genotyping, and phenotyping services, ensures the delivery of reliable research models and support to pharmaceutical, biotechnology, and academic institutions globally. Through strategic partnerships and investments in research and development, Taconic Biosciences continues to drive advancements in the field of mice model research and preclinical studies.